| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.01uM, methyl 5-[(E)-(tert-butylcarbamothioylhydrazinylidene)methyl]-1-(2,4-difluorophenyl)pyrazole-4-carboxylate, GPR35 antagonist targeting GPR35 (Novartis, 9581011) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/9581011 |
| Similar Terms | |
| Downloads & Tools |
2 genes differentially expressed following the AA-85-KR83_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| PPDPF | pancreatic progenitor cell differentiation and proliferation factor | 0.875999 |
| Symbol | Name | Standardized Value |
|---|---|---|
| CCDC22 | coiled-coil domain containing 22 | -0.304395 |